Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Hartl

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Journal of Personalized Medicine|February 25, 2022
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral SuppressionMathias Jachs, Lukas Hartl, David Bauer, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2024
Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity-Authors' replyNina Dominik, Georg Semmler, Lukas Hartl, et al.
Applied and Environmental Microbiology|February 5, 2005
Role of the bga1-encoded extracellular {beta}-galactosidase of Hypocrea jecorina in cellulase induction by lactoseBernhard Seiboth, Lukas Hartl, Noora Salovuori, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Cellular Microbiology|June 17, 2016
GH16 and GH81 family β-(1,3)-glucanases in Aspergillus fumigatus are essential for conidial cell wall morphogenesisIsabelle Mouyna, Vishukumar Aimanianda, Lukas Hartl, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Hepatology (Baltimore, Md.)|December 27, 2023
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosisBenedikt S Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Journal of Personalized Medicine|February 25, 2022
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral SuppressionMathias Jachs, Lukas Hartl, David Bauer, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2024
Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity-Authors' replyNina Dominik, Georg Semmler, Lukas Hartl, et al.
Applied and Environmental Microbiology|February 5, 2005
Role of the bga1-encoded extracellular {beta}-galactosidase of Hypocrea jecorina in cellulase induction by lactoseBernhard Seiboth, Lukas Hartl, Noora Salovuori, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Cellular Microbiology|June 17, 2016
GH16 and GH81 family β-(1,3)-glucanases in Aspergillus fumigatus are essential for conidial cell wall morphogenesisIsabelle Mouyna, Vishukumar Aimanianda, Lukas Hartl, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Hepatology (Baltimore, Md.)|December 27, 2023
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosisBenedikt S Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Pageof 13